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Summary
Objective: Osteoarthritis (OA) is the most common form of arthritis and patients with meniscal and ligament injuries of the knee are at high
risk to develop the disease. The purpose of this study was to evaluate changes occurring in both medial and lateral menisci from the knees
of anterior cruciate ligament (ACL) transected rabbits at 3 and 8 weeks post-surgery. This study describes both molecular and cellular
alterations in menisci during the early stages of OA development.
Design: Rabbit meniscal tissues were processed for molecular analysis: DNA and RNA concentrations were assessed, as well as
semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) analysis for a subset of relevant molecules was performed.
In situ DNA fragmentation was evaluated using the TUNEL assay.
Results: Total RNA yields from the medial meniscus were significantly elevated at both 3 and 8 weeks post-ACL transection, while in the
lateral meniscus total RNA levels were unchanged following ACL transection. DNA concentrations were significantly decreased in the medial
menisci only at 8 weeks post-ACL transection. Following ACL transection, analysis of in situ DNA fragmentation using the TUNEL assay
demonstrated an increase in the number of apoptotic cells in the medial meniscus only, in particular at 3 weeks post-ACL transection, a
finding which correlates with declines in DNA content. Analysis of specific mRNA levels by RT-PCR demonstrated complex changes in both
menisci following ACL transection. At 3 and 8 weeks post-ACL transection, in both medial and lateral menisci, mRNA levels for type I collagen
and TIMP-1 were significantly increased, while mRNA levels for decorin, TNF- and IGF-2 were significantly depressed. In the medial
meniscus, significant increases in mRNA levels for type II collagen, biglycan as well as iNOS and PAI-1 were detected at both time periods,
while mRNA levels for aggrecan, type III collagen and COX-2 were significantly elevated at 3 weeks post-ACL transection and mRNA levels
for MMP-1 were significantly elevated at 8 weeks post-ACL transection. In contrast, mRNA levels for COL2 and aggrecan were unchanged
in the lateral meniscus following ACL transection. In the lateral meniscus, at 3 weeks post-ACL transection, type III collagen mRNA levels
were dramatically increased while fibromodulin mRNA levels were significantly depressed. In the lateral meniscus, significant increases in
mRNA levels for biglycan were detected at 8 weeks post-ACL transection.
Conclusion: These results show that after ACL transection complex molecular changes, as well as apoptosis, occur early, particularly in the
medial meniscus. © 2001 OsteoArthritis Research Society International
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Meniscus injury is one of the causes of secondary osteo-
arthritis (OA).1,2 To date, there have been no reports of
molecular changes within menisci during the early stages
of OA development. In a concurrent study, histological
changes occuring in both medial and lateral menisci follow-
ing ACL transection in the rabbit model of OA have been
described.3 Overt cellular and matrix alterations were found
within the medial meniscus only. Formation of intrameniscal
tears was detected at 3 weeks post-ACL transection and by658 weeks post-ACL transection every medial meniscus
presented with a bucket-handle tear. Histologic examina-
tion demonstrated extensive changes in collagen fiber
organization as well as the coexistence of acellular areas
and large cell clusters located in the outer ridge of the tear.
No significant histologic changes were detected in the
lateral meniscus following ACL transection. In addition,
significant increase in staining for type I and III collagens
was demonstrated in both menisci while type II collagen
staining was increased only in the medial meniscus.
Based on our previous study, we hypothesized that the
cellular and matrix changes of the menisci during the early
stages of OA development would be reflected by alterations
in cellular activities. Therefore, molecular changes in the
rabbit meniscal tissue after ACL transection were examined
using semi-quantitative reverse transcription-polymerase
chain reaction (RT-PCR). The pattern of mRNA expression
for a subset of potentially relevant molecules has been
assessed on RNA isolated from the medial and lateral
menisci of non-operated rabbits (age-matched controls),
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EXPERIMENTAL OA
Skeletally mature (12 months of age) female New
Zealand White rabbits (Reimans Fur Ranch; St. Agatha,
ON) were used in the present study. All rabbits had surgery
under sterile conditions using a general inhalational anes-
thetic (1% halothane and oxygen at 1 l/min). The surgical
procedure has been previously described.3 Animals
were housed in the Animal Resource Center (Faculty of
Medicine) in accordance with Canadian Council on Animal
Care Guidelines and with the approval of the Animal Care
Committee of the Faculty of Medicine.previously described.
TISSUE PREPARATION
All animals were sacrificed by Euthanyl overdose (MTC
Pharmaceuticals, Cambridge, ON) intravenously through
the lateral ear vein. The medial and lateral menisci were
carefully removed aseptically from the knee joint to avoid
capsular contamination of the tissue. Samples were then
stored at −80°C prior to processing. For TUNEL assay,
tissue sections from paraffin samples were prepared as
3described previously.RNA EXTRACTION
Total RNA from both menisci was extracted using
the TRIspin method as described previously.4 Total RNA
was quantified using the SyBr green reagent (FMC Bio-
Products; Rockland, ME) and a Perkin Elmer fluorimeter.
All samples were stored at −80°C until analyzed.REVERSE TRANSCRIPTION AND SEMI-QUANTITATIVE POLYMERASE
CHAIN REACTION
Reverse transcription (RT) was carried out with 1 g total
RNA using the random primers supplied in the StrataScript
(tm) RT-PCR kit (PDI BioScience, Aurora, ON). Using
rabbit specific primer sets described and validated in pre-
vious studies,5,6 aliquots of cDNA were amplified by PCR
as previously described.4,6,7 For all reported experiments,
conditions were determined to be in the linear range for
both the PCR amplification and the image analysis system
as described previously.5 Briefly, for each group of samples
(i.e. RNA from the medial and lateral menisci from operated
and non-operated rabbits) all of the samples were sub-jected to RT at the same time and subsequently, all
samples of cDNA amplified by PCR at the same time to
avoid any potential experiment to experiment variation in
efficiency. Each RT sample was first assessed for GAPDH
(housekeeping gene) cDNA. GAPDH mRNA levels in
menisci were found to be not significantly different between
controls, 3 weeks and 8 weeks post-ACL transected knees
in preliminary experiments. Following 21–22 PCR cycles,
previously shown to yield results in the linear range of the
method,6,8 the volumes were normalized and the PCR
repeated to yield very similar GAPDH integrated density
values. Once the GAPDH values were determined to be
similar and in the linear range of detection, the same
volumes of each sample were then used to assess the
cDNA levels for the remaining molecules of interest. Such
an experimental construct allowed for comparisons
between groups (i.e. operated vs. non-operated). For each
primer set the optimal cycle number was determined and
the resulting amplified bands analyzed by densitometry.
The no-RT controls were negative for each primer set
utilized, indicating genomic DNA contamination was un-
detectable. Integrated density values for the genes in
question were normalized to the GAPDH values to yield a
semi-quantitative assessment. Two independently isolated
clones of each amplified cDNA fragment have been
sequenced to verify the identity of the cDNA product.DNA CONTENT ANALYSIS
Using the method reported by Lipman,9 the DNA con-
tent was measured using a fluorophotometric assay as
10IN SITU DETECTION OF DNA FRAGMENTATION
For histochemical detection of DNA strand-breaks,
terminal deoxynucleotidyl transferase (TdT)-mediated
dUTP nick-end labeling (TUNEL) was carried out using an
ApopTag fluorescein in situ apoptosis detection kit (S7110;
Intergen, Purchase, NY) according to the manufacturer’s
instructions. Negative control slides were prepared by
substituting distilled water for TdT enzyme. Labeled nuclei
were distinguished from the negative nuclei counterstained
with DAPI and the percentage of nuclei that were positive
for the TUNEL assay was assessed. At least 3000 nuclei
per sample were counted.STATISTICAL ANALYSIS
DNA and Total RNA values are given as mean±standard
deviation of six rabbits. Comparisons were made using
one-way ANOVA and the BonFerroni test was subse-
quently applied as a post-test when comparing pairs of
group means. Differences with P-values of less than 0.05
were considered significant.ResultsCONCENTRATIONS OF DNA
The mean concentrations of DNA per mg dry weight of
tissue are given in Table I. The values for the lateral
menisci for both operated groups did not differ from those inand ACL transected rabbits at 3 and 8 weeks post-surgery.
The panel of molecules to be assessed was determined
based on either their known role in maintaining meniscus
function (matrix molecules, proteinases and proteinase
inhibitors) or their ability to influence matrix molecule and/or
proteinase or proteinase inhibitor expression [growth fac-
tors and enzymes whose products have potent regulatory
functions (COX-2 and iNOS)]. While not all inclusive, the
chosen molecules are representative of cellular activities
known to influence connective tissue function. The results
indicate that complex molecular changes in the pattern of
mRNA expression for both the medial and the lateral
menisci occur early following ACL transection. In addition,
apoptotic events occurred that were meniscus-specific and
time-dependent.
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tion, the mean value for the medial meniscus was signifi-
cantly depressed to 66% of control values (P<0.01).CONCENTRATIONS OF RNA
The mean concentrations of total RNA per mg wet weight
of tissue are summarized in Table I. Total RNA levels in
the medial menisci were significantly elevated to 126% and
184% of control values at 3 and 8 weeks post-ACL transec-
tion (P<0.05 and P<0.01, respectively). Total RNA levels
were elevated in the lateral menisci after ACL transection,
but not significantly.
The mean values for the ratio of g RNA/g DNA are
presented in Table I. After ACL transection, the lateral
menisci exhibited a slight elevation in their RNA/DNA ratio,
whereas in the medial meniscus there was a dramatic
increase in the RNA/DNA ratio at 8 weeks post-ACL
transection (358% of control values).RT-PCR ANALYSIS
Specific transcript levels from ACL-transected and non-
operated control rabbits were analysed by semi-
quantitative RT-PCR. Transcripts levels for structural matrix
macromolecules (type I, II and III collagens, aggrecan,
biglycan, decorin and fibromodulin), matrix metalloprotein-
ases: MMP-1 (collagenase) and MMP-3 (stromelysin); pro-
teinase inhibitors (TIMP-1 and PAI-1), growth factors
(IGF-2 and TGF-), the cytokine TNF- and the enzymes
COX-2 and iNOS are presented in Figs 1, 2 and 3.Table I
DNA concentration per mg dry weight and total RNA concentration per mg wet weight of medial and lateral
menisci
Medial
(N=6)
Lateral
(N=6)
Control
3 weeks
post-ACL-T
8 weeks
post-ACL-T Control
3 weeks
post-ACL-T
8 weeks
post-ACL-T
DNA 6.13 5.39 3.97 5.32 5.76 7.56
S.D. 0.43 0.89 0.65 0.37 1.86 1.15
P value 0.003 0.09
(BonFerroni post-test) (b**)
RNA g/mg tissue 0.233 0.358 0.52 0.24 0.32 0.395
S.D. 0.02 0.08 0.06 0.08 0.16 0.028
P value 0.0001 0.168
(BonFerroni post-test) (a*) (b**)
g RNA/g DNA ratio 0.038 0.066 0.131 0.045 0.056 0.052
(a): 3 weeks post-ACL-T vs. control; (b): 8 weeks post-ACL-T vs. control; *P<0.05; **P<0.01.Fig. 1. Influence of ACL transection on mRNA levels for matrix
macromolecules in the medial and lateral menisci. mRNA levels
were determined by semi-quantitative RT-PCR as described in
Materials and methods. The mean value for each molecule from the
non-operated controls was set as 100% and the mean±S.E.M. values
from the operated animals are presented as per cent of control
values (N=6). All values indicated by an * are significantly different
from control values (P<0.05). (a: 3 w. post-ACL-T vs. Control;
b: 8 w. post-ACL-T vs. Control; *P<0·05; **P<0·01; ***P<0·001).Matrix macromolecules
Collagen type I mRNA levels were significantly increased
at both 3 and 8 weeks post-ACL transection in both the
lateral (P<0.001) and the medial menisci (P<0.05 and
P<0.01, respectively). Transcripts for type II collagen were
significantly elevated only in the medial meniscus, at both
3 and 8 weeks post-ACL transection (P<0.05). Type III
collagen mRNA levels in the lateral meniscus of operated
rabbits were dramatically increased to 1303% of control
values at 3 weeks post-ACL transection (P<0.001) and to582% of control values at 8 weeks post-ACL transection
(P<0.05). In the medial meniscus, mRNA levels for type III
collagen were significantly increased to 463% of control
68 M.-P. Hellio Le Graverand et al.: Meniscal changes in experimental osteoarthritisvalues at 3 weeks post-ACL transection only (P<0.05).
Aggrecan mRNA levels were significantly increased in the
medial meniscus of the operated rabbits at 3 weeks
post-surgery (P<0.05), but had returned to near control
values at 8 weeks post-ACL transection; no changes
were observed in the lateral meniscus for this molecule.
Transcripts for biglycan were significantly elevated at
both 3 and 8 weeks post-ACL transection in the medial
menisci (P<0.05 and P<0.01, respectively), and only at
8 weeks post-ACL transection in the lateral menisci
(P<0.05). In contrast, mRNA levels for decorin in both the
medial and lateral menisci were dramatically depressed to
31% and 30% of control values, respectively, at 3 weeks
post-ACL transection (P<0.001), and to 21% and 62% of
control values, respectively, at 8 weeks post ACL transec-
tion (P<0.001 and P<0.05, respectively). In addition,
fibromodulin mRNA levels were significantly depressed in
the lateral meniscus at 3 weeks post-ACL transection only
(P<0.01). The decrease in mRNA levels for fibromodulin
was not significant in the medial meniscus at either time
period.Proteinases and inhibitors
MMP-1 (collagenase) mRNA levels were significantly
elevated in the medial meniscus of operated rabbits only at
8 weeks post-ACL transection (P<0.05). In contrast, levels
were unchanged in the lateral meniscus after ACL transec-
tion. Transcript levels for MMP-3 (stromelysin) were not
modified after ACL transection in either the medial and the
lateral menisci. mRNA levels for TIMP-1 were significantly
elevated to 435% and 305% of control values in the lateral
meniscus at 3 and 8 weeks post-ACL transection, respect-
ively (P<0.001 and P<0.01, respectively). In the medial
meniscus, mRNA levels for TIMP-1 were also elevated at 3
and 8 weeks post-ACL transection (P<0.01). PAI-1 mRNA
levels were unchanged in the lateral meniscus following
ACL transection, while PAI-1 mRNA levels were signifi-
cantly increased in the medial meniscus at both 3 and
8 weeks post-ACL transection (P<0.05 and P<0.01,
respectively).Fig. 2. Effect of ACL transection on mRNA levels for MMPs and
proteinase inhibitors in the medial and lateral menisci. mRNA
levels were determined by semi-quantitative RT-PCR as described
in Materials and methods. The mean value for each molecule from
the non-operated controls was set as 100% and the mean±S.E.M.
values from the operated animals are presented as per cent of
control values (N=6). All values indicated by an * are significantly
different from control values (P<0.05). (a: 3 w. post-ACL-T vs.
Control; b: 8 w. post-ACL-T vs. Control; *P<0·05; **P<0·01;
***P<0·001).Fig. 3. Influence of ACL transection on mRNA levels for TNF-,
growth factors, iNOS, and COX-2 in the medial and lateral menisci.
mRNA levels were determined by semi-quantitative RT-PCR as
described in Materials and methods. The mean value for each
molecule from the nonoperated controls was set as 100% and the
mean±S.E.M. values from the operated animals are presented as
per cent of control values (N=6). All values indicated by an * are
significantly different from control values (P<0.05). (a: 3 w. post-
ACL-T vs. Control; b: 8 w. post-ACL-T vs. Control; *P<0·05;
**P<0·01; ***P<0·001).Growth factors
Transcript levels for TGF- were unchanged after ACL
transection in both the lateral and medial menisci at both
periods of sacrifice. In contrast, dramatic decreases in the
Osteoarthritis and Cartilage Vol. 9 No. 1 69levels of IGF-2 were observed at both 3 and 8 weeks
post-ACL transection in both the medial (P<0.001 and
P<0.01, respectively) and the lateral meniscus (P<0.001)
of operated rabbits.Cytokine
Transcript levels for TNF- were dramatically depressed
at both 3 and 8 weeks post-ACL transection in both the
medial meniscus (P<0.01), and the lateral meniscus
(P<0.05) of operated rabbits.COX-2 and iNOS
COX-2 mRNA levels were not modified after ACL
transection in the lateral meniscus. In contrast, mRNA
levels for COX-2 were significantly elevated to 276% of
control values in the medial meniscus at 3 weeks post-ACL
transection only (P<0.001). Similarly iNOS mRNA levels
were unchanged after ACL transection in the lateral menis-
cus and mRNA levels for iNOS were dramatically elevated
to 766% and 514% of control values in the medial meniscus
of operated rabbits at both 3 and 8 weeks post-ACL
transection (P<0.01 and P<0.05, respectively).IN SITU DETECTION OF DNA FRAGMENTATION
To determine whether apoptosis plays a role in the
progressive decline in the DNA concentration of the medial
menisci following ACL transection, in situ DNA fragmenta-
tion of both medial and lateral menisci at 3 and 8 weeks
post-ACL transection was assessed. Control lateral and
medial menisci displayed no TUNEL-positive nuclei. In
contrast, at 3 weeks post-ACL transection, medial menisci
exhibited a characteristic increase in the number of
TUNEL-positive nuclei in the peripheral aspect of the tear
forming in the meniscus substance corresponding to the
previously described proteoglycan-rich and cellular region3
(28% of the nuclei were positive for TUNEL assay)
[Fig. 4(A)]. Only a few TUNEL-positive nuclei were
observed in the remaining meniscal tissue (0.1% of the
nuclei were positive for TUNEL assay). At 8 weeks post-
ACL transection, the medial menisci exhibited significantly
fewer TUNEL-positive nuclei (0.01% of the nuclei were
positive for TUNEL assay) which were randomly dispersed
throughout the meniscal substance but never located within
cell clusters [Fig. 4(B)]. Lateral menisci displayed no
TUNEL-positive nuclei at either 3 and 8 weeks post-ACL
transection.Discussion
This report demonstrates that the transection of the ACL
leads to complex changes in rabbit knee menisci at the
molecular and cellular levels, and that the observed
changes are both meniscus-specific and time-dependent.
These findings extend and support previous observations
indicating that histologic changes occur primarily in the
medial meniscus following ACL transection, and begin to
establish a molecular basis for the observed histologic
alterations.
While no variations in total RNA concentration were
found in the lateral meniscus at either of the two time
periods following surgery, total RNA concentration in themedial meniscus was significantly increased at both 3 and
8 weeks-post-ACL transection. Interestingly, when normal-
ized to DNA concentrations, the medial menisci of 3 and 8
weeks ACL transected rabbits contained 138% and 358%,
respectively, of the synthetic machinery of controls in terms
of total RNA (mRNA+tRNA+rRNA). This suggests that the
cells of the rabbit medial meniscus are hypermetabolic after
joint injury due to ACL transection. This is consistent with
the report from Stockwell and Billingham that indicated
meniscal cells acquire abundant golgi and endoplasmic
reticulum consistent with a hypermetabolic state.11 This
anabolic activation appears to be characteristic of the
medial meniscus, since no significant variations in either
DNA or total RNA concentrations were found in the lateral
meniscus following ACL transection. Sample to sample
variation in the lateral menisci (Table I) may have obscured
changes in this tissue, particularly at the 3 week time point.
The present report also demonstrated complex mRNA
changes in both medial and lateral menisci following ACL
transection in this lapine model of OA. In both medial and
lateral menisci, mRNA levels for the major matrix macro-
molecules, collagen types I and III, as well as the small
dermatan sulfate PG biglycan, were significantly increased,
while those for the small dermatan sulfate PG decorin were
significantly reduced. These findings suggest that although
gross pathological as well as histological changes were
relatively moderate in the lateral meniscus compared with
the medial meniscus,3 molecular changes occur at the
mRNA level in the lateral meniscus in response to joint
injury following ACL transection.
The relative proportion of the collagens and the proteo-
glycans in menisci determines physical properties, and any
changes in these proportions may influence tissue behav-
ior. Interestingly, following ACL transection, the cells of the
medial meniscus exhibited a pattern of mRNA expression
that corresponds to a more fibrochondrocytic phenotype,
with significantly increased mRNA levels not only for type I
and III collagens, but also for type II collagen and aggrecan
(at least at 3 weeks post-ACL transection for the latter). The
discoordinate expression of type II collagen and aggrecan
mRNA levels observed at 8 weeks post-ACL transection is
consistent with the findings previously reported by Matyas
et al. in the canine model of OA.12,13 In contrast, the lateral
meniscus exhibited a pattern of mRNA expression that
correspond more to a fibroblastic phenotype, with highly
significant increases in mRNA levels for collagens type I
and III only and significantly depressed mRNA levels for
fibromodulin (at least at 3 weeks post-ACL transection).
The former is highly significant considering that normal
mRNA levels for type I and III collagens are significantly
higher in the medial meniscus compared with the lateral
meniscus in skeletally mature rabbits.10 Interestingly, fibro-
modulin is also a small keratan sulfate PG that has been
shown to inhibit formation of fibrils in a solution of type I
collagen.14 Moreover, fibromodulin has been described to
be present in highest amounts in the inner third of porcine
menisci, corresponding to the hyaline-like cartilage region
of the porcine menisci.14 Very interestingly, these findings
for the collagens at the molecular level correlate with our
previously reported increase in staining for type I and III
collagens in the lateral menisci and for type I, II and III
collagens in the medial menisci.3 Such findings support the
conclusion that meniscus-specific cellular responses at the
mRNA level occur following ACL transection.
Transection of the ACL did not lead to any detectable
changes in mRNA levels for MMP-3 in either the medial or
the lateral meniscus. In contrast, while mRNA levels for
70 M.-P. Hellio Le Graverand et al.: Meniscal changes in experimental osteoarthritisFig. 4. Apoptotic nuclei in the medial meniscus. Micrographs of sections of medial meniscus at 3 and 8 weeks post-ACL transection. In situ
analysis of DNA fragmentation detected by fluorescein-conjugated nucleotide labeling of 3′-OH DNA ends. Labeled nuclei were visualized
under fluorescence for TUNEL-positive nuclei. At 3 weeks post-ACL transection, labeled nuclei were mostly located in the meniscal outer
region with a few TUNEL-positive nuclei within the remaining meniscal tissue (Panel A). At 8 weeks post ACL transection, fewer labeled
nuclei were randomly dispersed throughout the meniscal tissue (Panel C). Panels B and D represent the DAPI counterstained nuclei
corresponding to the corresponding sections (Panels A and C, respectively).
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ACL transection, a significant increase in MMP-1 transcript
levels was observed at 8 weeks post-ACL transection in
the medial meniscus. The more severe morphological
alterations observed in the medial meniscus could be the
result of enzymatic degradation of the extracellular matrix,
possibly through the action of MMP-1 or other MMPs not
assessed. Only two MMPs and two proteinase inhibitors
were assessed at the mRNA level in the present study.
Other potential MMPs, such as the collagenases MMP-13
and MMP-8, could be implicated in the degradation of the
meniscal matrix, as it has been described in osteoarthritic
articular cartilage.15,16 Moreover, one must keep in mind
that the activity of the MMPs is regulated not only at the
transcriptional level, but also at the translational and post-
translational levels (activation of the enzyme and inhibition
through various proteinase inhibitors) and only mRNA
levels were assessed in this study.
The dramatic decreases in mRNA levels for TNF-
observed in both menisci suggest this cytokine does not
play a major role in matrix alterations in early OA. In
contrast, COX-2 mRNA levels were signifcantly increased
only in the medial meniscus. COX-2 is an inducible enzyme
whose products (i.e. prostaglandins) have been shown to
have potent regulatory functions on cells.17 Increased
levels of prostaglandin E products of COX-2 could also
influence the proteinase-proteinase inhibitor balance in the
tissue.18 The involvement of COX-2 in the changes occur-
ing in the medial menisci could be defined in the future
through the use of COX-2 specific inhibitors.
The DNA concentration in the medial meniscus was
significantly reduced by 34% at 8 weeks post-ACL tran-
section. In contrast, no variations in DNA concentration
were found in the lateral meniscus. Considering the large
acellular areas described in the medial menisci at 8 weeks
post-ACL transection,3 the significant reduction in DNA
content within the medial meniscus at 8 weeks post-ACL
transection probably reflects cell loss. This conclusion was
supported by the analysis of in situ DNA fragmentation in
menisci by the TUNEL assay. While no evidence for in situ
apoptosis was detectable in either control menisci or lateral
menisci from ACL transected knees, a significant increase
in the number of apoptotic nuclei was detected in medial
menisci at 3 and 8 weeks post-ACL transection. At 3 weeks
post-ACL transection, some of the apoptotic nuclei were
located throughout the meniscal tissue, but the large
majority were located in the previously described
proteoglycan-rich and cellular region located on the outer
side of the fissure.3 Only a few apoptotic nuclei were
observed throughout the meniscal tissue at 8 weeks
post-ACL transection. In contrast to the recent study of
Hashimoto et al.,19 in which the presence of apoptotic cells
was reported within rabbit meniscal cell clusters at 9 weeks
following ACL transection, in the present study apoptotic
nuclei were never located within the cell clusters that were
detected along the edges of the bucket-handle tear. The
time course of the detection of these apoptotic cell probably
explains the changes in DNA content. The occurrence of
apoptotic nuclei and the mRNA levels for the enzyme iNOS
also may be related. iNOS mRNA levels were dramatically
increased only in the medial meniscus, following ACL
transection. Assuming the increases in iNOS mRNA levels
are reflected by elevated protein activity, the dramatic
increase in iNOS mRNA levels in the medial meniscus
could be related to the observed elevation in apoptotic
nuclei and subsequent decrease in DNA concentration in
this tissue. The present results also support the report ofHashimoto et al., describing nitric oxide production and
apoptosis in cells of the meniscus in this rabbit model of
OA.19 In addition, it is probably relevant that mRNA levels
for IGF-2 were dramatically depressed following ACL
transection in the present study. In several animal models,
IGF-2 expression by pancreatic islet cells, as well as
neuroblastoma cells, has been shown to be associated
with a reduction in both NO production and apoptotic
events.20–22 Moreover, similar observations have been
reported with equine fetal and neonatal chondrocytes
in vitro.23 Therefore, in the medial meniscus IGF2 suppres-
sion, as well as increased iNOS mRNA levels, could
pre-dispose to development and progression of apoptosis.
However, the IGF2 mRNA suppression in the lateral menis-
cus does not appear to be related to apoptotic events.
In conclusion, the present study demonstrates that dur-
ing the early phases of joint responses to ACL transection
complex mRNA changes occur in the menisci that are
consistent with structural changes. Changes in mRNA
levels for type I, II and III collagens correlated with previous
detection of increased collagen staining in the menisci
following ACL transection.3 The decrease in DNA content
in the medial meniscus at 8 weeks post-ACL transection
correlated with the detection of apoptotic events, and iNOS
and IGF2 mRNA changes. Based on the significant medial
meniscus-specific increases in mRNA levels for iNOS and
COX-2, future studies will determine whether therapeutic
interventions such as iNOS and/ or COX-2 inhibitors can
alter disease progression in this model system.Acknowledgments
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